-
1321
Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023
Published 2025-12-01“…Human Vaccines & Immunotherapeutics…”
Get full text
Article -
1322
Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
Published 2025-12-01“…Human Vaccines & Immunotherapeutics…”
Get full text
Article -
1323
Knowledge, attitude, practices, and associated factors toward cervical cancer among female health sciences students of Addis Ababa University, Addis Ababa, Ethiopia
Published 2025-01-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
1324
Thanks to Reviewers
Published 2025-01-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
1325
Monkeypox: a re-emergent virus with global health implications – a comprehensive review
Published 2025-01-01“…Tropical Diseases, Travel Medicine and Vaccines…”
Get full text
Article -
1326
Exploring primary care physicians’ role in travel medicine: a scoping review of knowledge, practices, and training
Published 2025-02-01“…Tropical Diseases, Travel Medicine and Vaccines…”
Get full text
Article -
1327
Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain
Published 2018-01-01“…Potential use of cholera toxin (CT) as a mucosal vaccine adjuvant has been documented in a variety of animal models. …”
Get full text
Article -
1328
Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy
Published 2020-01-01“…The immune response elicited by the protective whole-cell pertussis (wP) versus the less-protective acellular pertussis (aP) vaccine has been well characterized; however, important clinical problems remain unsolved, as the inability of the currently administered aP vaccine is resulting in the reemergence of clinical disease (i.e., whooping cough). …”
Get full text
Article -
1329
-
1330
A lyophilised formulation of chimpanzee adenovirus vector for long-term stability outside the deep-freeze cold chain
Published 2025-01-01“…Abstract Background The adenovirus-vaccine platform has come to prominence with the COVID-19 vaccination campaigns. …”
Get full text
Article -
1331
Canada's First Universal Varicella Immunization Program: Lessons from Prince Edward Island
Published 2003-01-01“…Repeated media announcements and the cooperation of staff in schools and daycare facilities assisted in informing parents about the availability of the vaccine. Vaccine- associated adverse events have been uncommon and the vaccine has been well accepted.…”
Get full text
Article -
1332
QAAPT: an interoperable web-based open-source tool for antimicrobial resistance data analysis and visualisation
Published 2025-02-01“…The QAAPT tool was created by the Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia project, led by the International Vaccine Institute (IVI). This open-source web-based tool/application generates statistical and visual outputs of AMR data, offers data curation options, and can be integrated with laboratory information management systems. …”
Get full text
Article -
1333
Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use
Published 2017-01-01“…Personalized dendritic cell- (DC-) based vaccination has proven to be safe and effective as second-line therapy against various cancer types. …”
Get full text
Article -
1334
Automatic Generation of Validated Specific Epitope Sets
Published 2015-01-01“…Accurate measurement of B and T cell responses is a valuable tool to study autoimmunity, allergies, immunity to pathogens, and host-pathogen interactions and assist in the design and evaluation of T cell vaccines and immunotherapies. In this context, it is desirable to elucidate a method to select validated reference sets of epitopes to allow detection of T and B cells. …”
Get full text
Article -
1335
Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane
Published 2025-02-01“…The findings reported here can guide design of next-generation highly potent anti-EBOV therapeutics and vaccines.…”
Get full text
Article -
1336
Sensitivity and Optimal Control Analysis of an Extended SEIR COVID-19 Mathematical Model
Published 2022-01-01“…The sensitivity analysis carried out on this model showed that the vaccination rate and vaccine efficacy are among the most sensitive parameters of the vaccine reproduction number, RV. …”
Get full text
Article -
1337
Analysis of Production Function in Layer Chicken Business in Soppeng District
Published 2025-01-01“…Independent variables consisted of seedlings, labor, cage area, farmer experience, Newcastle Disease (ND) vaccine, Avian Influenza (AI) vaccine, concentrate feed, ground corn feed and bran feed. …”
Get full text
Article -
1338
Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity
Published 2025-01-01“… Background: Antibody-dependent cell-mediated cytotoxic (ADCC) response mediated by natural killer (NK) cells correlates with decreased infection risk in studies involving simian immunodeficiency virus (SIV)/simian-human immunodeficiency virus (SHIV), and human immunodeficiency virus (HIV) vaccine candidates. Currently, the heterogeneities of the functional subset of rhesus macaque natural killer (RMNK) cells are under-characterized. …”
Get full text
Article -
1339
Population-Based Surveillance of HiB Invasive Infections in Children in British Columbia, Alberta and Ontario -- 1995 to 1997
Published 2000-01-01“…OBJECTIVE: To assess vaccine effectiveness through enhanced disease surveillance following the change in childhood immunization programs in 1995, when all provinces and territories chose to use polyribosyl ribitol phosphate-tetanus protein (PRP-T) Haemophilus influenzae type b (Hib) conjugate vaccine, generally in combination with diphtheria-pertussis-tetanus inactivated polio vaccine (DPT-IPV) (as PENTA vaccine) because the protective efficacy of this regimen had not been directly measured.…”
Get full text
Article -
1340
Characterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination therapy
Published 2024-07-01“…Transcriptional analysis of CD8 T cells after the first treatment cycle with effector cells generated following yellow fever virus (YFV-17D) vaccine-induced infection was also compared.Results An early proliferative (Ki-67+) CD8 T-cell response was observed after cycle 1 in 60 patients (58.3%). …”
Get full text
Article